philadelphia cyberknife: lung cancer awareness month
DESCRIPTION
As the second-most common cancer in both men and women, lung cancer is responsible for the majority of cancer-related deaths. The American Cancer Society estimates more than 160,000 people will lose their battle with lung cancer this year, accounting for more victims than breast, prostate, colon and pancreatic cancers combined. In recognition of National Lung Cancer Awareness Month in November, Philadelphia CyberKnife encourages local residents to take preventive steps to protect themselves and their loved ones from common and lesser-known causes of lung cancer.TRANSCRIPT
Lung Cancer Awareness
Month
Philadelphia CyberKnife is a service of Delaware County Memorial Hospital
2010 West Chester Pike Suite 115 Havertown, PA 19083 (610) 446-‐6850 www.phillycyberknife.com
November is dedicated to increasing public understanding of lung cancer, including its prevalence, approaches to screening and prevention and treatment options.
Please note: The information presented here is not all-inclusive. Rather, it represents a starting point to learn
more about medical conditions and treatment options. There is no substitute for consulting a medical professional.
November is Lung Cancer Awareness Month
The Facts: Lung cancer is the leading cause of cancer death. • It is estimated that smoking is the principal cause of
about 90% of lung cancer in men and almost 80% in women.
• About 226,160 new cases of lung cancer will be
diagnosed in 2012 (116,470 in men and 109,690 in women).
• Cigarette smoking is the leading cause of most lung cancers, but there are other factors, too. Exposure to asbestos, radon, environmental factors or secondhand smoke can cause lung cancer.
Source: American Cancer Society
2010 West Chester Pike Suite 115 Havertown, PA 19083 (610) 446-‐6850 www.phillycyberknife.com
Risk Factors Prevention • Tobacco use. • Secondhand smoke from
others’ cigarettes. • Radon gas in the home. • Chronic lung disease such
as emphysema. • Family history or increased
age.
• Don't smoke. If you do smoke, quit now.
• Avoid secondhand smoke.
There is no risk-free level of secondhand smoke exposure.
• Have your home tested for
radon and take corrective action if high levels are found.
• Follow screening guidelines
recommended by the American Lung Association.
2010 West Chester Pike Suite 115 Havertown, PA 19083 (610) 446-‐6850 www.phillycyberknife.com
2010 West Chester Pike Suite 115 Havertown, PA 19083 (610) 446-‐6850 www.phillycyberknife.com
Philadelphia CyberKnife is a service of Delaware County Memorial Hospital, a member of the Crozer-Keystone Health System, which offers a lung cancer screening program. Crozer-Keystone Health System developed the program based on a national study published in the New England Journal of Medicine. The screenings provide low-dose CT scans capable of detecting tumors earlier and reducing lung cancer mortality rate by 20 percent for smokers. To learn more or find out if you or a loved one are eligible for a screening, click here.
Lung Cancer Prevention: The Crozer-Keystone Screening Program
Photo courtesy of Crozer-‐Keystone Health System
2010 West Chester Pike Suite 115 Havertown, PA 19083 (610) 446-‐6850 www.phillycyberknife.com
Lung Cancer Treatment Options Surgery: Some patients have small tumors that can be removed surgically, but they may suffer from other medical problems that prevent them from being surgical candidates or they may be opposed to surgery. In these cases, important treatment options like CyberKnife® offer an alternative.
Stereotactic Body Radiation Therapy: Stereotactic radiosurgery systems like the CyberKnife® can offer effective treatment of lung tumors while carrying a low risk of side effects. Treatment is noninvasive, spares healthy tissue and typically involves three to five outpatient procedures.
External-Beam Radiation Therapy: For patients who cannot tolerate surgery, external-beam radiation therapy (EBRT) is an option, although this treatment can be lengthy and difficult for some patients to endure. EBRT delivers focused radiation to a tumor but also encompasses a large margin of normal tissue.
Our Center
Philadelphia CyberKnife established the first CyberKnife® program in the greater Philadelphia area, giving our physicians the most experience treating patients with this technology in our region. Lung cancer is a frequently treated disease at our center. Our patients have come from throughout the eastern United States, as well as numerous countries around the world, including England, India and Malaysia. Philadelphia CyberKnife is a service of Delaware County Memorial Hospital, a member of the Crozer-Keystone Health System.
Medical Director: Dr. Luther Brady Associate Medical Director: Dr. John Lamond DCMH Chief of Radiation Oncology: Dr. Rachelle Lanciano Chief Medical Physicist: Jun Yang, Ph.D. DABR Research Nurse: Michael Good, RN Site Manager: Samuel Nalbone, MBA
Other Resources
2010 West Chester Pike Suite 115 Havertown, PA 19083 (610) 446-‐6850 www.phillycyberknife.com